| Literature DB >> 26619479 |
Andrea T Cruz1, Amina Ahmed2, Anna M Mandalakas3, Jeffrey R Starke4.
Abstract
Treatment of latent tuberculosis infection (LTBI) is an effective way of preventing future cases of tuberculosis disease. We review pediatric and adult studies of LTBI treatment (isoniazid and rifampin monotherapy, isoniazid plus rifampin, isoniazid plus rifapentine, and rifampin plus pyrazinamide). Based upon this review and our pediatric experience, we can offer recommendations for routine (isoniazid) and alternative courses of therapy.Entities:
Keywords: Adherence; Directly Observed Preventive Therapy; Latent Tuberculosis Infection
Year: 2013 PMID: 26619479 DOI: 10.1093/jpids/pit030
Source DB: PubMed Journal: J Pediatric Infect Dis Soc ISSN: 2048-7193 Impact factor: 3.164